Ozempic microdosing involves taking a lower dosage of the Semaglutide (Ozempic or Wegovy)than the manufacturer recommends. The goal is to achieve the same (or better) health outcomes with less medication.
What is Microdosing Ozempic?
Microdosing Ozempic involves either:
Taking a lower dose of the drug at the recommended frequency
Taking the recommended dose less frequently
For example, the recommended treatment dose of Semaglutide (Ozempic) is 1mg per week. So a patient seeking to microdose the medication may take Ozempic at 0.25mg or 0.5mg per week, or 1mg every 10 days.
Microdosing Ozempic is off-label, meaning that it is not supported by a strong body of clinical evidence. Most clinical trials were conducted using Ozempic at a 1mg per week dosage (ie, “Treatment dose Ozempic”), with smaller 0.25mg and 0.5mg per week of Ozempic used in the initial 4-8 weeks as the “run-up period” to get patients acclimatised to the medication. To date, there are no published clinical studies looking at the outcomes from microdose Ozempic, although there are several trials ongoing.
Ozempic comes in an auto-injector pen, which has a fixed number of clicks corresponding to the dosage (see chart below)
Caption: Microdosing Ozempic involves counting clicks on the auto-injector pen
Known Benefits of Microdosing Ozempic
Reduce the side effects of Ozempic For certain individuals, the side effects of Ozempic hit hard, especially the gastrointestinal side effects of nausea, bloating, acid reflux, diarrhoea or constipation. The side effects may become unbearable at treatment doses of Ozempic, necessitating a return to low-dose Ozempic
Conserve medication in times of shortage Due to a global shortage of Ozempic, many patients have tried to “stretch” their limited supplies of the medication while waiting for resupply
Weight and health maintenance After the initial 12 months of treatment, after a healthy weight and blood sugar level have been achieved, many patients continue with low dose Ozempic to maintain the effects. Completely stopping treatment has been shown to lead to significant weight regain, aka “Ozempic Rebound”, and deterioration of cardio-metabolic health.
Caption: Semaglutide (Ozempic and Wegovy) acts on GLP-1 receptors throughout the body
Emerging Benefits of Microdosing Ozempic
Ozempic and Alzheimers Disease Several clinical trials are investigating semaglutide, the active ingredient in Ozempic, as a potential treatment for Alzheimer's disease, with results expected in 2026. Early studies suggest semaglutide may reduce the risk of developing Alzheimer's, and some research indicates it could slow cognitive decline and brain shrinkage in individuals with Alzheimer's. GLP-1 medications like semaglutide protect the brain by improving blood vessel health, reducing inflammation, and potentially impacting metabolic processes linked to Alzheimer's disease. It is important to note that these are preliminary findings, and more research is needed to confirm the efficacy and safety of GLP-1 drugs in Alzheimer's treatment.
Ozempic, mental health and addiction Ozempic and other GLP-1 receptor medication acts on the brain not only to suppress appetite, but also to decrease cravings for substances, including alcohol. Patients on Ozempic have reported benefits in mood and emotional stability with less anxiety and depression. Ozempic is currently being studied for the treatment of alcohol abuse disorder and other psychiatric disorders, with several small-scale publications showing benefit.
Ozempic and longevity The recently published SELECT trial, following 17,604 patients with obesity and cardiovascular disease, compared semaglutide (Ozempic) versus placebo for 3 years. During the follow-up period, of the 833 trial participants who died, there was a significant risk reduction in cardiovascular and non-cardiovascular death amongst patients who were treated with Ozempic. While the evidence supporting the use of Ozempic in patients with obesity, diabetes and heart disease is clear, the benefits of Ozempic treatment in otherwise healthy patients for purposes of longevity are currently under investigation.
Caption: Ozempic comes in 0.25mg/0.5mg starter pen and a 1mg treatment pen
Reasons to Microdose Ozempic
Tapering off from standard treatment dosages- maintenance treatment
This is probably the most common reason why a patient would microdose Ozempic- to maintain the results from Ozempic treatment after coming off a ~12 month treatment course of Ozempic.
Gradual weight loss
Patients who wish to achieve their weight loss goals more gradually, over a longer time period, may consider microdose Ozempic
Avoid side effects
Patients who are experiencing significant side effects from Ozempic at treatment doses may wish to consider low-dose Ozempic
Reduce the risk of Ozempic Face
Ozempic Face develops due to excessive and rapid weight loss. With the gradual weight loss from low-dose Ozempic, the risk of developing Ozempic face is lower.
Affordability
Treatment with Ozempic is not cheap and is not always covered by insurance. Patients who are able to experience good results at lower Ozempic doses may decide to microdose Ozempic to save costs.
Conclusion
Semaglutide (Ozempic, Wegovy and Rybelsus) is the “blockbuster” medication of the decade, with multiple benefits that appear to extend beyond diabetes and weight loss. Low-dose Ozempic, aka microdose Ozempic, remains an area of ongoing research, with emerging benefits in Alzheimer’s disease, Mental health and longevity.
